0001185185-18-000739.txt : 20180425 0001185185-18-000739.hdr.sgml : 20180425 20180425101354 ACCESSION NUMBER: 0001185185-18-000739 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180425 DATE AS OF CHANGE: 20180425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIZONE INTERNATIONAL INC CENTRAL INDEX KEY: 0000753772 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870412648 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-224119 FILM NUMBER: 18773078 BUSINESS ADDRESS: STREET 1: 350 EAST MICHIGAN AVENUE STREET 2: SUITE 500 CITY: KALAMAZOO STATE: MI ZIP: 49007 BUSINESS PHONE: (269) 202-5020 MAIL ADDRESS: STREET 1: 350 EAST MICHIGAN AVENUE STREET 2: SUITE 500 CITY: KALAMAZOO STATE: MI ZIP: 49007 FORMER COMPANY: FORMER CONFORMED NAME: MADISON FUNDING INC DATE OF NAME CHANGE: 19860413 RW 1 medizone-rw042518.htm RW

MEDIZONE INTERNATIONAL, INC. 
350 East Michigan Avenue, Suite 500
 Kalamazoo, Michigan  49007

April 25, 2018 

VIA E-MAIL AND EDGAR SUBMISSION
Securities and Exchange Commission
Attention: John Reynolds
Division of Corporate Finance 
Mail Stop 3561
100 F Street N.W. 
Washington, D.C. 20549 
Re:          Medizone International, Inc.
Withdrawal of Registration Statement on Form S-1, File No. 333-224119
Ladies and Gentlemen: 
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Medizone International, Inc. (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of its Registration Statement on Form S-1, File No. 333-224119 (as amended, together with all exhibits thereto, the “Registration Statement”), effective as of the date hereof or at the earliest practicable date hereafter. The Registration Statement was filed by the Company on April 3, 2018; Amendment No. 1 was filed by the Company on April 13, 2018.
The Registration Statement has not been declared effective by the Commission, and no securities have been issued or sold under the Registration Statement.
The Company requests that, in accordance with Rule 457(p) under the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.
If you have any questions with respect to this matter, please contact the Company’s counsel, Kevin Pinegar of Durham Jones & Pinegar, P.C., at (801) 415-3000. 
 
     
Sincerely,
 
MEDIZONE INTERNATIONAL, INC.
   
 
 
/s/ David A. Dodd
  
 
 
David A. Dodd
Chief Executive Officer

cc:           Pamela Howell
Jonathan Burr